Virtual Audit Readiness: Preparing for Remote FDA Inspections in Biotech
As regulatory agencies embrace digital transformation, remote FDA inspections have become a standard practice, especially in biotech and pharmaceutical environments. These virtual audits offer flexibility and speed, but they also demand precision, preparation, and digital fluency. For biotech companies, being inspection-ready means adapting compliance strategies to meet FDA expectations in a virtual format. Why Remote […]